Neuromelanin-sensitive MRI identified as a potential biomarker for psychosis

(NIH/National Institute of Mental Health) Researchers have shown that a type of magnetic resonance imaging -- called neuromelanin-sensitive MRI (NM-MRI) -- is a potential biomarker for psychosis. NM-MRI signal was found to be a marker of dopamine function in people with schizophrenia and an indicator of the severity of psychotic symptoms in people with this mental illness. The study was funded, in part, by the National Institute of Mental Health (NIMH), part of the National Institutes of Health.